$VERB
Verb Technology Company, Inc. Stock $verb

$verb Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000149315222022852 Filed on August 15, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$2.187M	$2.399M	$2.691M
YoY Change	-24.59%	0.29%	6.36%
Cost Of Revenue	$736.0K	$835.0K	$973.0K
YoY Change	-32.23%	-25.38%	-20.25%
Gross Profit	$1.451M	$1.564M	$1.718M
YoY Change	-20.01%	22.86%	31.15%
Gross Profit Margin	66.35%	65.19%	63.84%
Selling, General & Admin	$6.965M	$6.562M	$7.036M
YoY Change	13.62%	0.31%	-4.14%
% of Gross Profit	480.01%	419.57%	409.55%
Research & Development	$1.372M	$1.382M	$1.580M
YoY Change	-60.95%	-56.99%	-45.14%
% of Gross Profit	94.56%	88.36%	91.97%
Depreciation & Amortization	$840.0K	$0.00	$495.0K
YoY Change	109.48%		20.73%
% of Gross Profit	57.89%	0.0%	28.81%
Operating Expenses	$9.127M	$8.339M	$9.025M
YoY Change	-9.12%	-17.88%	-15.18%
Operating Profit	-$7.676M	-$6.775M	-$7.307M
YoY Change	-6.72%	-23.72%	-21.68%
Interest Expense	$550.0K	$642.0K	$382.0K
YoY Change	-182.58%	7.72%	-3920.0%
% of Operating Profit
Other Income/Expense, Net	-$352.0K	$401.0K	-$64.00K
YoY Change	-4500.0%	-113.69%	-228.0%
Pretax Income	-$8.028M	-$6.374M	-$6.989M
YoY Change	-8.82%	-46.04%	-16.3%
Income Tax
% Of Pretax Income
Net Earnings	-$8.028M	-$6.374M	-$6.989M
YoY Change	-8.82%	-46.04%	-16.3%
Net Earnings / Revenue	-367.08%	-265.69%	-259.72%
Basic Earnings Per Share	-$0.08	-$0.07	-$3.66
Diluted Earnings Per Share	-$78.62K	-$65.74K	-$91.41K
COMMON SHARES
Basic Shares Outstanding	102.4M shares	96.95M shares	1.911M shares
Diluted Shares Outstanding	2.553M shares	2.424M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$921.0K	$5.547M	$3.718M
YoY Change	-74.82%	-13.99%	-71.29%
Cash & Equivalents	$921.0K	$5.547M	$3.718M
Short-Term Investments
Other Short-Term Assets	$738.0K	$894.0K	$714.0K
YoY Change	-18.45%	-29.33%	-35.09%
Inventory
Prepaid Expenses	$738.0K	$894.0K
Receivables	$1.438M	$1.816M	$1.536M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$3.097M	$8.257M	$5.968M
YoY Change	-48.86%	-4.53%	-60.94%
LONG-TERM ASSETS
Property, Plant & Equipment	$582.0K	$627.0K	$2.194M
YoY Change	-89.19%	-80.52%	-35.47%
Goodwill	$19.76M	$19.76M
YoY Change
Intangibles	$2.966M	$3.318M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$306.0K	$306.0K	$293.0K
YoY Change	-3.47%	356.72%	318.57%
Total Long-Term Assets	$31.69M	$32.15M	$32.13M
YoY Change	6.21%	15.76%	13.48%
TOTAL ASSETS
Total Short-Term Assets	$3.097M	$8.257M	$5.968M
Total Long-Term Assets	$31.69M	$32.15M	$32.13M
Total Assets	$34.78M	$40.41M	$38.10M
YoY Change	-3.08%	10.94%	-12.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.833M	$3.413M	$3.598M
YoY Change	-47.36%	-28.15%	-30.14%
Accrued Expenses	$3.851M	$3.466M	$4.945M
YoY Change	73.16%	51.09%	115.0%
Deferred Revenue	$1.549M	$1.614M
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$4.171M	$4.120M	$5.767M
YoY Change	10327.5%	2610.53%	1547.71%
Total Short-Term Liabilities	$16.40M	$14.16M	$19.52M
YoY Change	-9.61%	-27.13%	16.56%
LONG-TERM LIABILITIES
Long-Term Debt	$150.0K	$875.0K	$875.0K
YoY Change	-82.86%	0.0%	-9.79%
Other Long-Term Liabilities	$1.705M	$1.841M	$1.874M
YoY Change	-30.8%	-29.95%	-32.83%
Total Long-Term Liabilities	$1.855M	$2.716M	$2.749M
YoY Change	-44.44%	-22.47%	-26.89%
TOTAL LIABILITIES
Total Short-Term Liabilities	$16.40M	$14.16M	$19.52M
Total Long-Term Liabilities	$1.855M	$2.716M	$2.749M
Total Liabilities	$18.25M	$16.88M	$22.27M
YoY Change	-15.03%	-26.42%	8.65%
SHAREHOLDERS EQUITY
Retained Earnings	-$137.4M	-$129.4M
YoY Change
Common Stock	$10.00K	$10.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$16.53M	$23.53M	$15.82M
YoY Change
Total Liabilities & Shareholders Equity	$34.78M	$40.41M	$38.10M
YoY Change	-3.08%	10.94%	-12.61%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$8.028M	-$6.374M	-$6.989M
YoY Change	-8.82%	-46.04%	-16.3%
Depreciation, Depletion And Amortization	$840.0K	$0.00	$495.0K
YoY Change	109.48%		20.73%
Cash From Operating Activities	-$4.973M	-$5.103M	-$5.899M
YoY Change	8.04%	-23.84%	-14.75%
INVESTING ACTIVITIES
Capital Expenditures	-$191.0K	-$1.848M	-$2.366M
YoY Change	-91.89%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$3.000K
YoY Change		-100.0%	-70.0%
Cash From Investing Activities	-$191.0K	-$1.848M	-$2.363M
YoY Change	-91.89%	-184900.0%	-23730.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	538.0K	8.780M	11.04M
YoY Change	-87.09%	4449.22%	-38.82%
NET CHANGE
Cash From Operating Activities	-4.973M	-5.103M	-5.899M
Cash From Investing Activities	-191.0K	-1.848M	-2.363M
Cash From Financing Activities	538.0K	8.780M	11.04M
Net Change In Cash	-4.626M	1.829M	2.781M
YoY Change	65.75%	-128.11%	-75.04%
FREE CASH FLOW
Cash From Operating Activities	-$4.973M	-$5.103M	-$5.899M
Capital Expenditures	-$191.0K	-$1.848M	-$2.366M
Free Cash Flow	-$4.782M	-$3.255M	-$3.533M
YoY Change	112.72%	-51.42%	-48.95%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001566610
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	VERB	Stock Issued During Period Value Commitment Fee Related To Equity Line Of Credit Agreement StockIssuedDuringPeriodValueCommitmentFeeRelatedToEquityLineOfCreditAgreement		usd
	VERB	Stock Issued During The Conversion Of Series A Preferred To Common Stock StockIssuedDuringTheConversionOfSeriesAPreferredToCommonStock		usd
	VERB	Stock Issued During The Conversion Of Class B Units To Common Shares StockIssuedDuringTheConversionOfClassBUnitsToCommonShares		usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease		usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware		usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts		usd
	VERB	Fair Value Of Derivative Liability Extinguished FairValueOfDerivativeLiabilityExtinguished		usd
	VERB	Reclassification Of Class B Upon Conversion To Common Stock ReclassificationOfClassBUponConversionToCommonStock		usd
	VERB	Fair Value Of Common Stock Issued To Settle Notes Payable Related Party FairValueOfCommonStockIssuedToSettleNotesPayableRelatedParty		usd
	VERB	Fair Value Of Common Stock Issued For Future Services FairValueOfCommonStockIssuedForFutureServices		usd
	VERB	Discount Recognized From Advances On Future Receipts DiscountRecognizedFromAdvancesOnFutureReceipts		usd
	VERB	Fair Value Of Common Stock Issued To Settle Lawsuit FairValueOfCommonStockIssuedToSettleLawsuit		usd
	VERB	Accrued Software Development Costs AccruedSoftwareDevelopmentCosts		usd
	VERB	Discount Recognized From Convertible Notes Payable DiscountRecognizedFromConvertibleNotesPayable		usd
	VERB	Derecognition Of Operating Lease Right Of Use Assets DerecognitionOfOperatingLeaseRightOfUseAssets		usd
	VERB	Derecognition Of Operating Lease Liabilities DerecognitionOfOperatingLeaseLiabilities		usd
	VERB	Recognition Of Operating Lease Rightofuse Asset And Related Lease Liability RecognitionOfOperatingLeaseRightofuseAssetAndRelatedLeaseLiability		usd
CY2021Q4	VERB	Notes Payable Related Parties Debt Discount NotesPayableRelatedPartiesDebtDiscount		usd
CY2021Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	2162000	usd
	VERB	Gain On Extinguishment Of Derivative Liability GainOnExtinguishmentOfDerivativeLiability		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
	VERB	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeited In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
	VERB	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P6M
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38834
	dei	Entity Registrant Name EntityRegistrantName	Verb Technology Company, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-1118043
	dei	Entity Address Address Line1 EntityAddressAddressLine1	3401 North Thanksgiving Way
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 240
	dei	Entity Address City Or Town EntityAddressCityOrTown	Lehi
	dei	Entity Address State Or Province EntityAddressStateOrProvince	UT
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	84043
	dei	City Area Code CityAreaCode	(855)
	dei	Local Phone Number LocalPhoneNumber	250-2300
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	102425699	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5547000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	937000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1816000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1382000	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	894000	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	875000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	8257000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	3194000	usd
CY2022Q2	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	6461000	usd
CY2021Q4	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	4348000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	627000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	702000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1673000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2177000	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3318000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3953000	usd
CY2022Q2	us-gaap	Goodwill Goodwill	19764000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	19764000	usd
CY2022Q2	us-gaap	Other Assets OtherAssets	306000	usd
CY2021Q4	us-gaap	Other Assets OtherAssets	293000	usd
CY2022Q2	us-gaap	Assets Assets	40406000	usd
CY2021Q4	us-gaap	Assets Assets	34431000	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3413000	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3751000	usd
CY2022Q2	us-gaap	Interest Payable Current InterestPayableCurrent	1780000	usd
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	3500000	usd
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1215000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1209000	usd
CY2022Q2	VERB	Advances On Future Receipts Net AdvancesOnFutureReceiptsNet	554000	usd
CY2021Q4	VERB	Advances On Future Receipts Net AdvancesOnFutureReceiptsNet	4181000	usd
CY2022Q2	us-gaap	Notes Payable Current NotesPayableCurrent	4120000	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	40000	usd
CY2021Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	521000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	471000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	592000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1614000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	986000	usd
CY2022Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	993000	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	3155000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	14160000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	17935000	usd
CY2022Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	875000	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	875000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1841000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2299000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	16876000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	21109000	usd
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000	shares
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	101958787	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	101958787	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	72942948	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	72942948	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	10000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	7000	usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	10000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	7000	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	152910000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	129342000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-129390000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-116027000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	23530000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	13322000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	40406000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	34431000	usd
CY2022Q2	VERB	Revenue From Contract With Customer Excluding Assessed Tax From Digital Revenue RevenueFromContractWithCustomerExcludingAssessedTaxFromDigitalRevenue	2161000	usd
CY2021Q2	VERB	Revenue From Contract With Customer Excluding Assessed Tax From Digital Revenue RevenueFromContractWithCustomerExcludingAssessedTaxFromDigitalRevenue	1810000	usd
	VERB	Revenue From Contract With Customer Excluding Assessed Tax From Digital Revenue RevenueFromContractWithCustomerExcludingAssessedTaxFromDigitalRevenue	4311000	usd
	VERB	Revenue From Contract With Customer Excluding Assessed Tax From Digital Revenue RevenueFromContractWithCustomerExcludingAssessedTaxFromDigitalRevenue	3611000	usd
CY2022Q2	VERB	Revenue From Contract With Customer Excluding Assessed Tax From Non Digital Revenue RevenueFromContractWithCustomerExcludingAssessedTaxFromNonDigitalRevenue	238000	usd
CY2021Q2	VERB	Revenue From Contract With Customer Excluding Assessed Tax From Non Digital Revenue RevenueFromContractWithCustomerExcludingAssessedTaxFromNonDigitalRevenue	582000	usd
	VERB	Revenue From Contract With Customer Excluding Assessed Tax From Non Digital Revenue RevenueFromContractWithCustomerExcludingAssessedTaxFromNonDigitalRevenue	779000	usd
	VERB	Revenue From Contract With Customer Excluding Assessed Tax From Non Digital Revenue RevenueFromContractWithCustomerExcludingAssessedTaxFromNonDigitalRevenue	1307000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2399000	usd
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2392000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5090000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4918000	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	835000	usd
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	1119000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1808000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	2334000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	1564000	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	1273000	usd
	us-gaap	Gross Profit GrossProfit	3282000	usd
	us-gaap	Gross Profit GrossProfit	2584000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1382000	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3213000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2962000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6097000	usd
CY2022Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	395000	usd
CY2021Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	400000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	804000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	814000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6562000	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6542000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13598000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13885000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	8339000	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	10155000	usd
	us-gaap	Operating Expenses OperatingExpenses	17364000	usd
	us-gaap	Operating Expenses OperatingExpenses	20796000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-6775000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-8882000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-14082000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-18212000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	642000	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	596000	usd
	us-gaap	Interest Expense InterestExpense	1398000	usd
	us-gaap	Interest Expense InterestExpense	1104000	usd
CY2022Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1024000	usd
CY2021Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-2445000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	2162000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1945000	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	19000	usd
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	20000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-45000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	74000	usd
CY2021Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	91000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1030000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	401000	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2930000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	719000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1945000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6374000	usd
CY2021Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11812000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13363000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-20157000	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.35
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	96953254	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	63147880	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	86762287	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57627324	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	13322000	usd
	us-gaap	Sale Of Stock Consideration Received Per Transaction SaleOfStockConsiderationReceivedPerTransaction	20150000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	377000	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1126000	usd
	VERB	Stock Issued During The Fair Value Of Common Shares Issued To Settle Accrued Expenses StockIssuedDuringTheFairValueOfCommonSharesIssuedToSettleAccruedExpenses	450000	usd
	VERB	Stock Issued During The Fair Value Of Vested Restricted Stock Awards Stock Options And Warrants StockIssuedDuringTheFairValueOfVestedRestrictedStockAwardsStockOptionsAndWarrants	1468000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13363000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	23530000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	15822000	usd
CY2022Q2	us-gaap	Sale Of Stock Consideration Received Per Transaction SaleOfStockConsiderationReceivedPerTransaction	12612000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	690000	usd
CY2022Q2	VERB	Stock Issued During The Fair Value Of Common Shares Issued To Settle Accrued Expenses StockIssuedDuringTheFairValueOfCommonSharesIssuedToSettleAccruedExpenses	100000	usd
CY2022Q2	VERB	Stock Issued During The Fair Value Of Vested Restricted Stock Awards Stock Options And Warrants StockIssuedDuringTheFairValueOfVestedRestrictedStockAwardsStockOptionsAndWarrants	680000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-6374000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	23530000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	10745000	usd
	us-gaap	Sale Of Stock Consideration Received Per Transaction SaleOfStockConsiderationReceivedPerTransaction	14129000	usd
	VERB	Stock Issued During Period Value From Warrants Exercise StockIssuedDuringPeriodValueFromWarrantsExercise	1103000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	377000	usd
	VERB	Stock Issued During The Fair Value Of Common Shares Issued To Settle Note Payable Related Party StockIssuedDuringTheFairValueOfCommonSharesIssuedToSettleNotePayableRelatedParty	200000	usd
	VERB	Stock Issued During The Fair Value Of Common Shares Issued To Settle Lawsuit StockIssuedDuringTheFairValueOfCommonSharesIssuedToSettleLawsuit	678000	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1769000	usd
	VERB	Stock Issued During The Fair Value Of Vested Restricted Stock Awards StockIssuedDuringTheFairValueOfVestedRestrictedStockAwards	905000	usd
	VERB	Stock Issued During The Fair Value Of Vested Stock Options And Warrants StockIssuedDuringTheFairValueOfVestedStockOptionsAndWarrants	870000	usd
	VERB	Stock Issued During The Extinguishment Of Derivative Liability Upon Exercise Of Warrants StockIssuedDuringTheExtinguishmentOfDerivativeLiabilityUponExerciseOfWarrants	2300000	usd
	VERB	Stock Issued During The Fair Value Of Common Shares Issued To Settle Accrued Expenses StockIssuedDuringTheFairValueOfCommonSharesIssuedToSettleAccruedExpenses	281000	usd
	VERB	Stock Issued During The Fair Value Of Warrants Issued To Officer To Modify Note Payable StockIssuedDuringTheFairValueOfWarrantsIssuedToOfficerToModifyNotePayable	287000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-20157000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	13487000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	23098000	usd
CY2021Q2	VERB	Stock Issued During The Fair Value Of Common Shares Issued To Settle Note Payable Related Party StockIssuedDuringTheFairValueOfCommonSharesIssuedToSettleNotePayableRelatedParty	200000	usd
CY2021Q2	VERB	Stock Issued During The Fair Value Of Common Shares Issued To Settle Lawsuit StockIssuedDuringTheFairValueOfCommonSharesIssuedToSettleLawsuit	678000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	355000	usd
CY2021Q2	VERB	Stock Issued During The Fair Value Of Vested Restricted Stock Awards StockIssuedDuringTheFairValueOfVestedRestrictedStockAwards	458000	usd
CY2021Q2	VERB	Stock Issued During The Fair Value Of Vested Stock Options And Warrants StockIssuedDuringTheFairValueOfVestedStockOptionsAndWarrants	422000	usd
CY2021Q2	VERB	Stock Issued During The Extinguishment Of Derivative Liability Upon Exercise Of Warrants StockIssuedDuringTheExtinguishmentOfDerivativeLiabilityUponExerciseOfWarrants	14000	usd
CY2021Q2	VERB	Stock Issued During The Fair Value Of Common Shares Issued To Settle Accrued Expenses StockIssuedDuringTheFairValueOfCommonSharesIssuedToSettleAccruedExpenses	74000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-11812000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	13487000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13363000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-20157000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2618000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	3666000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	908000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1040000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	264000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	2162000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1945000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1030000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	804000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	814000	usd
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-22000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-10000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	6000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	378000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	249000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	11000	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	4108000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	812000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	253000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	334000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	172000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	281000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	183000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	740000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	628000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	271000	usd
	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	-377000	usd
	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	-521000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-271000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-325000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11002000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13620000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	3000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	24000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	82000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4211000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	11000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	20150000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	14129000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	6000000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	7368000	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1103000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1896000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	4363000	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	4734000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	377000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	377000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	445000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	19823000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	18243000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4610000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4634000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	937000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1815000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5547000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6449000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13363000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11002000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_849_eus-gaap--UseOfEstimates_zYWtBo9jqEH7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zqgtg88GcG2g">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reported periods. </span>Management bases these estimates and assumptions upon historical experience, existing and known circumstances, and other factors that management believes to be reasonable. In addition, the Company has considered the potential impact of the pandemic, as well as certain macroeconomic factors, including inflation, rising interest rates, and recessionary concerns, on its business and operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant estimates include assumptions made in analysis of reserves for allowance of doubtful accounts, inventory, assumptions made in purchase price allocations, impairment testing of long-term assets, realization of deferred tax assets, determining fair value of derivative liabilities, and valuation of equity instruments issued for services. Some of those assumptions can be subjective and complex, and therefore, actual results could differ materially from those estimates under different assumptions or conditions. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p>
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-1000	usd
	VERB	Fair Value Of Derivative Liability Extinguished FairValueOfDerivativeLiabilityExtinguished	2300000	usd
CY2022Q2	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	6461000	usd
CY2021Q4	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	4348000	usd
CY2022Q2	us-gaap	Depreciation Depreciation	0	usd
CY2021Q2	us-gaap	Depreciation Depreciation	0	usd
	us-gaap	Depreciation Depreciation	0	usd
	us-gaap	Depreciation Depreciation	0	usd
	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<p id="xdx_844_eus-gaap--DerivativesReportingOfDerivativeActivity_zF43O230Rg91" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zniPGKdt4Gx3">Derivative Financial Instruments</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the condensed consolidated statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the condensed consolidated balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company uses Level 2 inputs for its valuation methodology for the derivative liabilities as their fair values were determined by using a Binomial pricing model. The Company’s derivative liabilities are adjusted to reflect fair value at each period end, with any increase or decrease in the fair value being recorded in results of operations as adjusted to fair value of derivatives.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zIaP9Bdly2Xk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_z6rZYN6sHAu6">Concentration of Credit and Other Risks</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash and accounts receivable. Cash is deposited with a limited number of financial institutions. The balances held at any one financial institution at times may be in excess of Federal Deposit Insurance Corporation (“FDIC”) insurance limits of up to $<span id="xdx_903_eus-gaap--CashFDICInsuredAmount_iI_pn3n3_c20220630_z7KNDSoBx5Z7" title="FDIC Insured Amount">250</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">The Company evaluates the concentration of credit risk associated with key customers. During the three and six months ended June 30, 2022 and 2021, we had no customers that accounted for <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220401__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_zewSIyhaeny4" title="Concentration risk, percentage"><span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210401__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_zk0mM7ZEKrJd" title="Concentration risk, percentage"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_zD00NSAzl9R8" title="Concentration risk, percentage"><span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20210630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_zC1ca8xdfWM4" title="Concentration risk, percentage">10</span></span></span></span>% of our revenues individually or in the aggregate.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company extends limited credit to customers based on an evaluation of their financial condition and other factors. The Company generally does not require collateral or other security to support accounts receivable. The Company performs ongoing credit evaluations of its customers and maintains an allowance for doubtful accounts and sales credits. The Company believes that any concentration of credit risk in its accounts receivable is substantially mitigated by the Company’s evaluation process, relatively short collection terms and credit worthiness of its customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">As of June 30, 2022 and December 31, 2021, we had no customers that accounted for <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zGm6CQiP1u8j" title="Concentration risk, percentage"><span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zGlMPlT0Tque" title="Concentration risk, percentage">10</span></span>% of our accounts receivable individually or in the aggregate.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-size: 10pt">The Company also evaluates the concentration of credit risk associated with key vendors</span><span style="font-size: 8pt">. </span> For the three and six months ended June 30, 2022, we had one vendor that accounted for <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220401__20220630__srt--MajorCustomersAxis__custom--OneVendorMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zHRyPWS5vcm" title="Concentration risk, percentage">44</span>% and <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220630__srt--MajorCustomersAxis__custom--OneVendorMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_ziZYaQSHUrwc" title="Concentration risk, percentage">41</span>%, respectively, of our purchases individually and in the aggregate. For the three and six months ended June 30, 2021, we had one vendor that accounted for <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210401__20210630__srt--MajorCustomersAxis__custom--OneVendorMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zXxcnu7GTXTg" title="Concentration risk, percentage">30</span></span>% and <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20210630__srt--MajorCustomersAxis__custom--OneVendorMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zJR4BXTJ5RY2" title="Concentration risk, percentage">28</span>%, respectively, of our purchases individually and in the aggregate. As of June 30, 2022 and December 31, 2021, we had one vendor that accounted for <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220630__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zGqTzvOttxFh" title="Concentration risk, percentage">41</span>% and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zUOBjCcBYsx1" title="Concentration risk, percentage">40</span>%, respectively, of accounts payable individually and in the aggregate.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_zgYYJCAwLOsa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Supplemental Cash Flow Information</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_zR1iQFes0hX8" style="display: none">SCHEDULE OF SUPPLEMENTAL CASH FLOW INFORMATION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_499_20220101__20220630_zyvEHU6nREG3" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49D_20210101__20210630_zRR4Qq2Fk5ya" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td colspan="5" style="border-bottom: Black 1.5pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><b>Six Months Ended June 30,</b></p> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><b>2022</b></p></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><b>2021</b></p></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--SupplementalCashFlowInformationAbstract_iB_zubhFYY1larl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Supplemental disclosures of cash flow information:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--InterestPaidNet_pn3n3_zOHgLXDPgun2" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 68%; text-align: left">Cash paid for interest</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">95</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">34</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--IncomeTaxesPaidNet_iN_pn3n3_di_zQcXLLsdVnza" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Cash paid for income taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_iB_zir3e6TCmyQe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Supplemental disclosure of non-cash investing and financing activities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--FairValueOfDerivativeLiabilityExtinguished_pn3n3_z1o8glihHiDk" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Fair value of derivative liability extinguished</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1045">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,300</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--FairValueOfCommonSharesIssuedToSettleAccruedExpenses_pn3n3_zYQyP02NxAq3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Fair value of common shares issued to settle accrued expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">450</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">281</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--ReclassificationOfClassBUponConversionToCommonStock_pn3n3_zIaI08Zvc4Cg" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Reclassification of Class B Units upon conversion to common stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1051">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,065</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--FairValueOfCommonStockIssuedToSettleNotesPayableRelatedParty_pn3n3_zTQIKCwgiMQb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Fair value of common stock issued to settle notes payable – related party</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1054">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">200</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--FairValueOfCommonStockReceivedInExchangeForEmployeesPayrollTaxes_pn3n3_zEm7qwZyT2q6" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Fair value of common stock received in exchange for employee’s payroll taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">130</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--FairValueOfCommonStockIssuedForFutureServices_pn3n3_zXadcZ5ZyNaf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Fair value of common stock issued for future services</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1060">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">164</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--DiscountRecognizedFromAdvancesOnFutureReceipts_pn3n3_zViQogJ8lgRc" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Discount recognized from advances on future receipts</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1063">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,986</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_ecustom--FairValueOfCommonStockIssuedToSettleLawsuit_pn3n3_ziDBGBnOLlR3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Fair value of common stock issued to settle lawsuit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1066">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">678</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--AccruedSoftwareDevelopmentCosts_pn3n3_zawm07DsnIA7" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Accrued software development costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">105</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1070">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--DiscountRecognizedFromConvertibleNotesPayable_pn3n3_zyywGxhFboQc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Discount recognized from notes payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">300</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1073">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--DerecognitionOfOperatingLeaseRightOfUseAssets_pn3n3_ziwR3OrNDukd" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Derecognition of operating lease right-of-use assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">543</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1076">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--DerecognitionOfOperatingLeaseLiabilities_pn3n3_ziK2dAvUxrxh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Derecognition of operating lease liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">521</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1079">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_405_ecustom--RecognitionOfOperatingLeaseRightofuseAssetAndRelatedLeaseLiability_pn3n3_ziJvgQf1u7W6" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Recognition of operating lease right-of-use asset and related lease liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">212</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1082">-</span></td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A1_z0VNPIQx97cl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
	us-gaap	Interest Paid Net InterestPaidNet	95000	usd
	us-gaap	Interest Paid Net InterestPaidNet	34000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-1000	usd
	VERB	Fair Value Of Common Shares Issued To Settle Accrued Expenses FairValueOfCommonSharesIssuedToSettleAccruedExpenses	450000	usd
	VERB	Fair Value Of Common Shares Issued To Settle Accrued Expenses FairValueOfCommonSharesIssuedToSettleAccruedExpenses	281000	usd
	VERB	Reclassification Of Class B Upon Conversion To Common Stock ReclassificationOfClassBUponConversionToCommonStock	3065000	usd
	VERB	Fair Value Of Common Stock Issued To Settle Notes Payable Related Party FairValueOfCommonStockIssuedToSettleNotesPayableRelatedParty	200000	usd
	VERB	Fair Value Of Common Stock Received In Exchange For Employees Payroll Taxes FairValueOfCommonStockReceivedInExchangeForEmployeesPayrollTaxes	6000	usd
	VERB	Fair Value Of Common Stock Received In Exchange For Employees Payroll Taxes FairValueOfCommonStockReceivedInExchangeForEmployeesPayrollTaxes	130000	usd
	VERB	Fair Value Of Common Stock Issued For Future Services FairValueOfCommonStockIssuedForFutureServices	164000	usd
	VERB	Discount Recognized From Advances On Future Receipts DiscountRecognizedFromAdvancesOnFutureReceipts	1986000	usd
	VERB	Fair Value Of Common Stock Issued To Settle Lawsuit FairValueOfCommonStockIssuedToSettleLawsuit	678000	usd
	VERB	Accrued Software Development Costs AccruedSoftwareDevelopmentCosts	105000	usd
	VERB	Discount Recognized From Convertible Notes Payable DiscountRecognizedFromConvertibleNotesPayable	300000	usd
	VERB	Derecognition Of Operating Lease Right Of Use Assets DerecognitionOfOperatingLeaseRightOfUseAssets	543000	usd
	VERB	Derecognition Of Operating Lease Liabilities DerecognitionOfOperatingLeaseLiabilities	521000	usd
	VERB	Recognition Of Operating Lease Rightofuse Asset And Related Lease Liability RecognitionOfOperatingLeaseRightofuseAssetAndRelatedLeaseLiability	212000	usd
CY2022Q2	VERB	Accrued Other Capitalized Software Development Costs AccruedOtherCapitalizedSoftwareDevelopmentCosts	389000	usd
CY2021Q4	VERB	Accrued Other Capitalized Software Development Costs AccruedOtherCapitalizedSoftwareDevelopmentCosts	248000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	7399000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	7317000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4523000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3806000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2876000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3511000	usd
CY2022Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	442000	usd
CY2021Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	442000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1673000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2177000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	471000	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3318000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3953000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	351000	usd
CY2021Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	355000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	717000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	725000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	717000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1386000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	573000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	200000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2876000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	241000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	349000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	308000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	393000	usd
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y1M24D
CY2021Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y3M3D
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.042	pure
CY2021Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.040	pure
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	592000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1841000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2299000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	2312000	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2891000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	300000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	583000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	472000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	484000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	705000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2544000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	232000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	2312000	usd
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	6617000	usd
CY2022Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	589000	usd
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	4981000	usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	35000	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	800000	usd
CY2022Q2	VERB	Advances On Future Receipts Net AdvancesOnFutureReceiptsNet	554000	usd
CY2021Q4	VERB	Advances On Future Receipts Net AdvancesOnFutureReceiptsNet	4181000	usd
CY2022Q2	VERB	Notes Payable Related Parties Debt Discount NotesPayableRelatedPartiesDebtDiscount	-128000	usd
CY2022Q2	VERB	Notes Payable Related Parties Debt Issuance Costs NotesPayableRelatedPartiesDebtIssuanceCosts	-196000	usd
CY2022Q2	us-gaap	Notes Payable NotesPayable	4995000	usd
CY2021Q4	us-gaap	Notes Payable NotesPayable	915000	usd
CY2022Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	875000	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	875000	usd
CY2022Q2	us-gaap	Notes Payable Current NotesPayableCurrent	4120000	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	40000	usd
CY2022Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	-372000	usd
CY2021Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	-565000	usd
CY2022Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	151000	usd
CY2022Q2	us-gaap	Interest Expense Other InterestExpenseOther	119000	usd
CY2021Q2	us-gaap	Interest Expense Other InterestExpenseOther	31000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	642000	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	596000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	-908000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	-1040000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	264000	usd
	us-gaap	Interest Expense Other InterestExpenseOther	226000	usd
	us-gaap	Interest Expense Other InterestExpenseOther	64000	usd
	us-gaap	Interest Expense InterestExpense	1398000	usd
	us-gaap	Interest Expense InterestExpense	1104000	usd
CY2022Q2	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	993000	usd
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	3155000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1945000	usd
CY2021Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	2300000	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	3155000	usd
CY2020Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	8266000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	2162000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1945000	usd
	VERB	Gain On Extinguishment Of Derivative Liability GainOnExtinguishmentOfDerivativeLiability	-2300000	usd
CY2022Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	993000	usd
CY2021Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	7911000	usd
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	463234	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1821833	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	1.41
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	1334270	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.17
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	463234	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	1.66
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	493481000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	1.33
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	2199388	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	1.23
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5404223	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.72
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y2M26D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	107000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	2689555	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.07
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1777379	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.59
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	332730	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.13
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5983669	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.45
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y9M29D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2982073	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	1.86
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	1741272	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	2.13
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	26	usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	332730	shares
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	377000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0124	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0301	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0010	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0092	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	1.478	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	1.495	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	2.362	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	2.400	pure
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	10984740	shares
CY2021Q4	VERB	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	2.67
	VERB	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms Beginning ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTermsBeginning	P2Y4M17D
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested	507000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	14666667	shares
	VERB	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice	0.75
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	25651407	shares
CY2022Q2	VERB	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	1.52
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P3Y7M24D
CY2022Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	14666667	shares
CY2022Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.75
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	200	usd
	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	300000	usd
CY2021Q4	us-gaap	Legal Fees LegalFees	915000	usd

Files In Submission

Name	View Source	Status
0001493152-22-022852-index-headers.html	Edgar Link	pending
0001493152-22-022852-index.html	Edgar Link	pending
0001493152-22-022852.txt	Edgar Link	pending
0001493152-22-022852-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
verb-20220630.xsd	Edgar Link	pending
verb-20220630_cal.xml	Edgar Link	unprocessable
verb-20220630_def.xml	Edgar Link	unprocessable
verb-20220630_lab.xml	Edgar Link	unprocessable
verb-20220630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VERB
Verb Technology Company, Inc. Stock $verb

2022 Q3 Form 10-Q Financial Statement

#000149315222022852 Filed on August 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VERB Verb Technology Company, Inc. Stock $verb

2022 Q3 Form 10-Q Financial Statement

#000149315222022852 Filed on August 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VERB
Verb Technology Company, Inc. Stock $verb